References
Alén M. Androgenic steroid effects on liver and red cells. British Journal of Sports Medicine 19: 15–20, 1985
Alén M, Rahkila P. Effects and side-effects of hormone doping. Proceedings of World Symposium on Doping in Sport, Florence, May 10–12, 1987, in press, 1988
Alén M, Rahkila P, Marniemi J. Serum lipids in power athletes self-administering testosterone and anabolic steroids. International Journal of Sports Medicine 6: 139–144, 1985a
Alén M, Rahkila P, Reinilä M, Vihko R. Androgenic-anabolic steroid effects on serum thyroid, pituitary and steroid hormones in athletes. American Journal of Sports Medicine 15: 357–361, 1987
Alén M, Reinilä M, Vihko R. Response of serum hormones to androgen administration in power athletes. Medicine and Science in Sports and Exercise 17: 354–359, 1985b
Applebaum-Bowden D, Haffner SM, Hazzard WR. The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol. Metabolism 36: 949–952, 1987
Barron JL, Noakes TD, Levy W, Smith C, Millar RP. Hypothalamic dysfunction in overtrained athletes. Journal of Clinical Endocrinology and Metabolism 60: 803–806, 1985
Bunt JC. Hormonal alterations due to exercise. Sports Medicine 3: 331–345, 1986
Caminos-Torres R, Ma L, Snyder PJ. Testosterone induced inhibition of the LH and FSH responses to gonadotropin-releasing hormone occurs slowly. Journal of Clinical Endocrinology and Metabolism 44: 1142–1153, 1977
Council on Scientific Affairs. Drug abuse in athletes: anabolic steroids and human growth hormone. Journal of the American Medical Association 259: 1703–1705, 1988
Crist DM, Peake GT, Stackpole PJ. Alpha-lipoproteinemic effects of androgenic-anabolic steroids in athletes. Annals of Sports Medicine 2: 125–128, 1985
Dimick DF, Heron M, Baulieu E, Jayle M. A comparative study of the metabolic fate of testosterone, 17α-methyltestosterone, 19-nortestosterone, 17α-methyl-19-nortestosterone and 17α-methyl-estr-5(10)-ene-17β-ol-3-one in normal males. Clinica Chimica Acta 6: 63–71, 1961
Ehnholm C, Huttunen JK, Kinnunen PJ, Miettinen TA, Nikkilä EA. Effect of oxandrolone treatment on the activity of lipoprotein lipase, hepatic lipase and phospholipase A1 of human postheparin plasma. New England Journal of Medicine 292: 1314–1317, 1975
Forbes GB. The effect of anabolic steroids on lean body mass: the dose response curve. Metabolism 34: 571–573, 1985
Fujioka M, Shinohara Y, Baba S, Irie M, Inoue K. Acute suppression of endogenous testosterone levels by exogenous testosterone in normal men. Life Sciences 41: 945–949, 1987
Godsland IF, Wynn V, Crook D, Miller NE. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. American Heart Journal 114: 1467–1503, 1987
Goldberg L, Elliot DL. The effect of exercise on lipid metabolism in men and women. Sports Medicine 4: 307–321, 1987
Goldberg RB, Rabin D, Alexander AN, Doelle GC, Getz GS. Suppression of plasma testosterone leads to increase in serum total and high density lipoprotein cholesterol and apoproteins A-I and B. Journal of Clinical Endocrinology and Metabolism 60: 203–207, 1985
Gooren LJG. Long-term safety of the oral androgen testosterone undecanoate. International Journal of Andrology 9: 21–26, 1986
Haffner SM, Kushwaha RS, Foster DM, Applebaum-Bowden D, Hazzard WR. Studies on the metabolic mechanisms of reduced high density lipoproteins during anabolic steroid therapy. Metabolism 32: 413–417, 1983
Haupt HA, Rovere GD. Anabolic steroids: a review of the literature. American Journal of Sports Medicine 12: 469–484, 1984
Hazzard WR, Haffner SM, Kushwaha RS, Applebaum-Bowden D, Foster SM. Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman. Metabolism 33: 779–784, 1984
Hervey G, Knibbs A, Burkinshow L, Morgan D, Jones P, et al. Effects of methandienone on the performance and body composition of men undergoing athletic training. Clinical Science 60: 457–461, 1981
Hurley BF, Kokkinos PF. Effects of weight training on risk factors for coronary artery disease. Sports Medicine 4: 231–238, 1987
Huttunen JK, Ehnholm C, Kekki M, Nikkilä EA. Postheparin plasma lipoprotein lipase in normal subjects and in patients with hypertriglyceridaemia; correlations to sex, age and various parameters of triglyceride metabolism. Clinical Science and Molecular Medicine 50: 249, 1976
Kantor MA, Bianchini A, Bernier D, Sady SP, Thompson PD. Androgens reduce HDL2-cholesterol and increase hepatic triglyceride lipase activity. Medicine and Science in Sports and Exercise 17: 462–465, 1985
Kiraly C, Alén M, Rahkila P, Horsmanheimo M. Effect of androgenic and anabolic steroids on the sebaceous gland in power athletes. Acta Dermato-Venereologica 67: 36–40, 1987b
Kiraly C, Collan Y, Alén M. Effect of testosterone and anabolic steroids on the size of sebaceous glands in power athletes. American Journal of Dermatopathology 9: 515–519, 1987a
Kirkland RT, Keenan BS, Probstfield JL, Patsch W, Lin T-L, et al. Decrease in plasma high-density lipoprotein cholesterol levels at puberty in boys with delayed adolescence: correlation with plasma testosterone levels. Journal of the American Medical Association 257: 502–507, 1987
Kopera H. The history of anabolic steroids and a review of clinical experience with anabolic steroids. Acta Endocrinologica 110(Suppl. 271): 11–18, 1985
Kuoppasalmi K, Adlercreutz H. Interaction between catabolic and anabolic steroid hormones in muscular exercise. In Fotherby & Pal (Eds) Exercise endocrinology, pp. 65–98, Walter de Gruyter & Co, Berlin - New York, 1985
Kuusi T, Saarinen P, Nikkilä EA. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Atherosclerosis 36: 589–593, 1980
Lamb DR. Anabolic steroids in athletics: how well do they work and how dangerous are they? American Journal of Sports Medicine 12: 31–38, 1984
Laskarzewski PM, Morrison JA, Gutai J, Orchard T, Khoury PR, et al. High and low density lipoprotein cholesterols in adolescent boys: relationships with endogenous testosterone, estradiol and Quetelet index. Metabolism 32: 262–265, 1983
Link K, Blizzard RM, Evans WS. The effect of androgens on the pulsatile release and the twenty-four hour mean concentrations of growth hormone in peripubertal males. Journal of Clinical Endocrinology and Metabolism 62: 159–164, 1986
Martikainen H, Alén M, Rahkila P, Vihko R. Testicular responsiveness to human chorionic gonadotropin during transient hypogonadotropic hypogonadism induced by androgic anabolic steroids in power athletes. Journal of Steroid Biochemistry 25: 109–112, 1986
Matsumine H, Hirato K, Ynaihara T, Tamada T, Yoshida M. Aromatization by skeletal muscle. Journal of Clinical Endocrinology and Metabolism 63: 717–720, 1986
Mooradian AD, Morley JE, Koreman SG. Biological actions of androgens. Endocrine Reviews 8: 1–28, 1987
Moorjani S, Dupont A, Labrie F, Lupien PJ, Brun D, et al. Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism 36: 244–250, 1987
Moorjani S, Dupont A, Labrie F, Lupien PJ, Gagné C, et al. Changes in plasma lipoproteins during various androgen suppression therapies in men with prostatic carcinoma: effects of orchiectomy, estrogen, and combination treatment with luteinizing hormone-releasing hormone agonist and flutamide. Journal of Clinical Endocrinology and Metabolism 66: 314–322, 1988
Morrison JA, Laskarzewski PM, Rauh JL, Brookman R, Mellies M, et al. Lipids, lipoproteins and sexual maturation during adolescence: the Princeton Maturation Study. Metabolism 28: 641–646, 1979
Murad F, Haynes RC. Androgens. In Gilman et al. (Eds) The pharmacological basis of therapeutics, pp. 1440–1458, Macmillan Publishing Company, New York, 1985
Parker MW, Johanson AJ, Rogol AD. Effect of testosterone on somatomedin-C concentration in prepubertal boys. Journal of Clinical Endocrinology and Metabolism 58: 87–90, 1984
Rahkila P, Alén M. Lipid and lipoprotein metabolism during androgenic steroid doping. Proceedings of World Symposium on Doping in Sport, Florence, May 10–12, 1987. In press, 1988
Rosenfield RL. Toward optimal estrogen-replacement therapy. New England Journal of Medicine 309: 1120–1121, 1983
Ruokonen A, Alén M, Bolton N, Vihko R. Response of serum testosterone and its precursor steroids, SHBG and CBG to anabolic steroid and testosterone self-administration in man. Journal of Steroid Biochemistry 23: 33–38, 1985
Schmitz G, Assmann G, Melnik B. The role of lecithin: cholesterol acyltransferase in high density lipoprotein3/high density lipoprotein2 interconversion. Clinica Chimica Acta 119: 225–236, 1981
Schürmeyer T, Knuth UA, Berkien L, Nieschlag E. Reversible azoospermia induced by the anabolic steroid 19-nortestosterone. Lancet 1: 417–420, 1984
Semmens J, Rouse I, Beilin J, Masarei JRL. Relationship of plasma HDL-cholesterol to testosterone, estradiol, and sex hormone-binding globulin levels in men and women. Metabolism 32: 428–432, 1983
Small M, Beastall GH, Semple CG, Cowan RA, Forbes, CD: Alteration of hormone levels in normal males given the anabolic steroid stanozolol. Clinical Endocrinology 21: 49–55, 1984
Sorva R, Kuusi T, Taskinen MR, Perheentupa J, Nikkilä EA. Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males. Atherosclerosis 69: 191–197, 1988
Taggart HMcA, Applebaum-Bowden D, Haffner S, Warnick GR, Cheung MC, et al. Reduction in high density lipoproteins by anabolic steroid (Stanozolol) therapy for postmenopausal osteoporosis. Metabolism 31: 1147–1152, 1982
Taskinen MR, Nikkilä EA. High density lipoprotein subfractions in relation to lipoprotein lipase activity of tissues in man — evidence for reciprocal regulation of HDL2 and HDL3 levels by lipoprotein lipase. Clinica Chimica Acta 112: 325–327, 1981
Tikkanen MJ, Nikkilä EA. Regulation of hepatic Hpase and serum lipoproteins by sex steroids. American Heart Journal 113: 562–567, 1987
Tikkanen MJ, Nikkilä EA, Kuusi T, Sipinen S. High density lipoprotein-2 and hepatic lipase: reciprocal changes produced by estrogen and norgestrel. Journal of Clinical Endocrinology and Metabolism 54: 1113–1117, 1982
Webb OL, Laskarzewski PM, Glueck CJ. Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids. Metabolism 33: 971–975, 1984
Weinberg RB. Lipoprotein metabolism: hormonal regulation. Hospital Practice 223–243, 1987
Wilson JD, Griffin JE. The use and misuse of androgens. Metabolism 29: 1278–1295, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Alén, M., Rahkila, P. Anabolic-Androgenic Steroid Effects on Endocrinology and Lipid Metabolism in Athletes. Sports Med 6, 327–332 (1988). https://doi.org/10.2165/00007256-198806060-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00007256-198806060-00001